Impact of Actinic Keratosis (AK), as measured by patient-reported AK symptoms, and impact on emotions and functioning (using Skindex-16) among patients with AK administered tirbanibulin in real-world community practices across the U.S. (PROAK Study). (2023). SKIN The Journal of Cutaneous Medicine, 7(2), s161. https://doi.org/10.25251/skin.7.supp.161